Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2025 Earnings Call Transcript February 12, 2026
Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.19.
Operator: Good day, and welcome to Pacific Biosciences of California, Inc.’s Fourth Quarter and Full Year 2025 Earnings Conference Call. All participants will be in listen-only mode. Please note that today’s event is being recorded. I would now like to turn the conference...
